Documentdetail
ID kaart

oai:pubmedcentral.nih.gov:8251...

Onderwerp
Research Articles
Auteur
Bhumkar, Akshay Magnan, Chloe Lau, Derrick Jun, Eugene Soh Wei Dzamko, Nicolas Gambin, Yann Sierecki, Emma
Langue
en
Editor

John Wiley and Sons Inc.

Categorie

Wiley-Blackwell Online Open

Jaar

2021

vermelding datum

01-12-2023

Trefwoorden
amplification methods α‐synuclein patients parkinson detection disease
Metriek

Beschrijving

α‐Synuclein aggregation is a hallmark of Parkinson's disease and a promising biomarker for early detection and assessment of disease progression.

The prospect of a molecular test for Parkinson's disease is materializing with the recent developments of detection methods based on amplification of synuclein seeds (e.g. RT‐QuIC or PMCA).

Here we adapted single‐molecule counting methods for the detection of α‐synuclein aggregates in cerebrospinal fluid (CSF), using a simple 3D printed microscope.

Single‐molecule methods enable to probe the early events in the amplification process used in RT‐QuIC and a precise counting of ThT‐positive aggregates.

Importantly, the use of single‐molecule counting also allows a refined characterization of the samples and fingerprinting of the protein aggregates present in CSF of patients.

The fingerprinting of size and reactivity of individual aggregate shows a unique signature for each PD patients compared to controls and may provide new insights on synucleinopathies in the future.

Bhumkar, Akshay,Magnan, Chloe,Lau, Derrick,Jun, Eugene Soh Wei,Dzamko, Nicolas,Gambin, Yann,Sierecki, Emma, 2021, Single‐Molecule Counting Coupled to Rapid Amplification Enables Detection of α‐Synuclein Aggregates in Cerebrospinal Fluid of Parkinson's Disease Patients, John Wiley and Sons Inc.

Delen

Bron

Artikelen aanbevolen door ES/IODE AI

Bone metastasis prediction in non-small-cell lung cancer: primary CT-based radiomics signature and clinical feature
non-small-cell lung cancer bone metastasis radiomics risk factor predict cohort model cect cancer prediction 0 metastasis radiomics clinical